Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Holders of 5% or more of DARE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Dare Bioscience, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Dare Bioscience, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Dare Bioscience, Inc., newest first, including old-format filings without a stake.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Dare Bioscience, Inc. shares.
No Form 144 notices for Dare Bioscience, Inc. are on file.